IonQ Elisity Acquisition Expands Quantum Cybersecurity
IonQ Elisity acquisition up to $1.3 billion combines IonQ's PQC and QKD with Elisity's Zero Trust platform and could shift investor positioning.
KEY TAKEAWAYS
- IonQ agreed to acquire Elisity in an all-stock transaction valued up to $1.3 billion.
- The deal combines IonQ's post-quantum cryptography and QKD with Elisity's enterprise Zero Trust platform.
- Consideration includes up to $150 million in performance-based earnouts and a reference-price range for share issuance.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
On Oct. 12, 2026, IonQ announced an all-stock agreement to acquire Elisity, combining its post-quantum cryptography and quantum key distribution capabilities with Elisity’s enterprise Zero Trust platform to expand its quantum cybersecurity offerings.
Deal Terms and Strategic Rationale
IonQ said in a press release that it entered a definitive agreement to acquire Elisity in an all-stock transaction valued at up to $1.3 billion. The deal merges IonQ’s post-quantum cryptography (PQC) and quantum key distribution (QKD) technologies with Elisity’s Zero Trust security platform. IonQ framed the acquisition as a move to accelerate Zero Trust security for the quantum era, aligning its encryption tools with an enterprise Zero Trust stack. This positions IonQ to broaden its cybersecurity products and enterprise go-to-market reach.
Consideration and Seller Details
The reported consideration includes up to $150 million in performance-based earnouts. Share issuance will be calculated using a reference price ranging from $33.07 to $49.61 per IonQ share. Elisity is a privately held, venture-backed Zero Trust cybersecurity company. As an all-stock deal, IonQ will issue equity rather than pay the full headline value in cash.
The acquisition integrates IonQ’s quantum-security technologies with established Zero Trust software, marking a strategic expansion into enterprise cybersecurity products and sales channels.
